These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 363629

  • 1. Treatment of obesity: comparison of physician and nonphysician therapists using placebo and anorectic drugs in a double-blind trial.
    Atkinson RL, Greenway FL, Bray GA, Dahms WT, Molitch ME, Hamilton K, Rodin J.
    Int J Obes; 1977; 1(2):113-20. PubMed ID: 363629
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A multicentre study comparing mazindol and placebo in obese patients.
    Walker BR, Ballard IM, Gold JA.
    J Int Med Res; 1977; 5(2):85-90. PubMed ID: 326596
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Slowed gastric evacuation accounts for the reduction of food intake by anorectic drugs.
    Jonderko K, Kucio C, Skrzypek D.
    Eur J Clin Nutr; 1988 Jul; 42(7):627-31. PubMed ID: 3066620
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical trial with a nonamphetaminic anoretic].
    Campagnoli M.
    Rev Iber Endocrinol; 1976 Jul; 23(137):463-83. PubMed ID: 794978
    [Abstract] [Full Text] [Related]

  • 12. A multi-centre general practice trial of mazindol in the treatment of obesity.
    Maclay WP, Wallace MG.
    Practitioner; 1977 Mar; 218(1305):431-4. PubMed ID: 322112
    [No Abstract] [Full Text] [Related]

  • 13. Double-blind trial of mazindol in overweight patients.
    Heber KR.
    Med J Aust; 1975 Oct 04; 2(14):566-7. PubMed ID: 1105106
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Long-term treatment of patients with obesity using mazindol and a reducing diet].
    van Seters AP, Bouwhuis-Hoogerwerf ML, Goslings BM, van Nieuwkoop L, van Slooten H, Struijk-Wielinga T.
    Ned Tijdschr Geneeskd; 1982 May 29; 126(22):990-4. PubMed ID: 7110390
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients.
    Bruera E, Carraro S, Roca E, Barugel M, Chacon R.
    Cancer Treat Rep; 1986 Feb 29; 70(2):295-8. PubMed ID: 3512080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.